(Q33806297)

29 July 2017

1 reference

title

MAL-PDT for difficult to treat nonmelanoma skin cancer (English)

1 reference

29 July 2017

1 reference

William G Stebbins

1

1 reference

29 July 2017

C William Hanke

series ordinal

2

1 reference

29 July 2017

publication date

1 January 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

24

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

82-93

1 reference

Incidence estimate of nonmelanoma skin cancer in the United States, 2006.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Low density lipoprotein receptor and cation-independent mannose 6-phosphate receptor are transported from the cell surface to the Golgi apparatus at equal rates in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Laser and non-laser light sources for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Body site distribution of Bowen's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Immediate whealing urticaria in red light exposed areas during photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Allergic contact dermatitis to methyl aminolevulinate (Metvix) cream used in photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Photodynamic therapy in dermatology: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01381.X

10.1111/J.1529-8019.2010.01381.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference